Monoclonal Ddit3 Antibody

<strong>Monoclonal Ddit3 Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2017037_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 5 µL_x000D_ <strong>Molecular Weight or Concentration:</strong> 29 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20¬∞C_x000D_ <strong>Keywords:</strong> CHOP, CEBPZ, CHOP10, CHOP-10, GADD153_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Diaz-Perez JA, Kerr DA. Gene of the month: DDIT3 J Clin Pathol. 2024 Mar 20;77(4):211-216._x000D_ 2: Scapa JV, Cloutier JM, Raghavan SS, Peters-Schulze G, Varma S, Charville GW. DDIT3 Immunohistochemistry Is a Useful Tool for the Diagnosis of Myxoid Liposarcoma Am J Surg Pathol. 2021 Feb 1;45(2):230-239._x000D_ 3: Baranov E, Black MA, Fletcher CDM, Charville GW, Hornick JL. Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas Mod Pathol. 2021 Jul;34(7):1367-1372._x000D_ 4: Oikawa K, Ishida T, Imamura T, Yoshida K, Takanashi M, Hattori H, Ishikawa A, Fujita K, Yamamoto K, Matsubayashi J, Kuroda M, Mukai K. Generation of the novel monoclonal antibody against TLS/EWS-CHOP chimeric oncoproteins that is applicable to one of the most sensitive assays for myxoid and round cell liposarcomas Am J Surg Pathol. 2006 Mar;30(3):351-6._x000D_ 5: Barzadd MM, Lundqvist M, Harris C, Malm M, Volk AL, Thal√©n N, Chotteau V, Grassi L, Smith A, Abadi ML, Lambiase G, Gibson S, Hatton D, Rockberg J. Autophagy and intracellular product degradation genes identified by systems biology analysis reduce aggregation of bispecific antibody in CHO cells N Biotechnol. 2022 May 25;68:68-76._x000D_ 6: Sigstad E, Paus E, Bj√∏ro T, Berner A, Gr√∏holt KK, J√∏rgensen LH, Sobrinho-Sim√µes M, Holm R, Warren DJ. The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors Mod Pathol. 2012 Apr;25(4):537-47._x000D_ 7: Liu J, Edagawa M, Goshima H, Inoue M, Yagita H, Liu Z, Kitajima S. Role of ATF3 in synergistic cancer cell killing by a combination of HDAC inhibitors and agonistic anti-DR5 antibody through ER stress in human colon cancer cells Biochem Biophys Res Commun. 2014 Mar 7;445(2):320-6._x000D_ 8: Peng F, Zhang H, Du Y, Tan P. Cetuximab enhances cisplatin-induced endoplasmic reticulum stress-associated apoptosis in laryngeal squamous cell carcinoma cells by inhibiting expression of TXNDC5 Mol Med Rep. 2018 Mar;17(3):4767-4776._x000D_ 9: Kumandan S, Mahadevan NR, Chiu K, DeLaney A, Zanetti M. Activation of the unfolded protein response bypasses trastuzumab-mediated inhibition of the PI-3K pathway Cancer Lett. 2013 Feb 28;329(2):236-42._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/22446330">10: Magnussen GI, Ree Rosnes AK, Shahzidi S, Dong HP, Emilsen E, Enges√¶ter B, Fl√∏renes VA. Synthetic retinoid CD437 induces apoptosis and acts synergistically with TRAIL receptor-2 agonist in malignant melanoma Biochem Biophys Res Commun. 2012 Apr 13;420(3):516-22. </a>_x000D_ _x000D_ <strong>Products Related to Monoclonal Ddit3 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>